Abstract

Among the diseases that can lead to miscarriage and premature termination of a planned pregnancy, hyperestrogenic conditions play an important role. The state of impaired synthesis of estradiol metabolites significantly affects the development of mastopathy, endometrial hyperplasia, impaired implantation of fertilized eggs, metabolic disorders in women and is a risk factor for cancer of the reproductive system.To date, the urgency of the problem of hormonal diseases of the female reproductive system, including the mammary glands, is beyond doubt. In this case, dyshormonal diseases of the breast are a reflection of hormonal disorders of the entire female body and serve as a basis for the development of breast cancer. The main method of treatment for dyshormonal processes is hormone replacement therapy, but currently there is an alternative to hormonal drugs, which include non-hormonal phytotherapeutic complexes based on the biologically active substances indole-3-carbinol, barberry extract and polyphenols that normalize estrogen antiproliferative activity, have an antioxidant effect, implement antitumor action.

Highlights

  • Modern approaches to the treatment of mastopathy and correction of hyperestrogenic conditions in women of fertile age Vl.V

  • Among the diseases that can lead to miscarriage and premature termination of a planned pregnancy, hyperestrogenic conditions play an important role

  • The state of impaired synthesis of estradiol metabolites significantly affects the development of mastopathy, endometrial hyperplasia, impaired implantation of fertilized eggs, metabolic disorders in women and is a risk factor for cancer of the reproductive system

Read more

Summary

Introduction

Modern approaches to the treatment of mastopathy and correction of hyperestrogenic conditions in women of fertile age Vl.V. Порушення синтезу метаболітів естрадіолу значною мірою впливає на розвиток дисгормональної патології репродуктивних органів – зокрема, гіперплазії ендометрія, порушення процесів імплантації заплідненої яйцеклітини, мастопатії, порушення процесів обміну речовин в організмі жінки – та є фактором ризику розвитку онкологічних захворювань [5]. Вони стимулюють проліферативну активність клітин органів репродуктивної системи, зокрема, можуть бути причиною розвитку раку грудної залози.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.